ArticleCancers2023

Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors.

Hans-Georg Lerchen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.